NeoStem acquiring cardiovascular company Amorcyte in a stock deal valued at $9.8 million

Amorcyte Inc.

U.S. / Private Biopharma

Seller

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

NeoStem Inc.

U.S. / Tools, Services, and Manufacturing

Buyer

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Completed

Sample

01/01/2009

announced

01/01/2009

completed